Skip to content
MedsAcross

Molecule

Sertaconazole

Also known as sertaconazole nitrate
Available on request
Presentations
1
Brands
1
Manufacturers
1
Available from stock
0

Sertaconazole is an azole antifungal indicated for the topical treatment of interdigital tinea pedis in immunocompetent adult and pediatric patients 12 years of age and older caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum. MedsAcross supplies Sertaconazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Azole Antifungal
US FDA first approval
10 December 2003
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Topical
Dosage forms
Cream
Identifiers
UNII 1DV05410M5RxCUI 236601CAS 99592-39-9Q27252298

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

ERTACZO ® cream, 2%, is indicated for the topical treatment of interdigital tinea pedis in immunocompetent adult and pediatric patients 12 years of age and older caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum. ERTACZO cream, 2% is an azole antifungal indicated for the topical treatment of interdigital tinea pedis in immunocompetent adult and pediatric patients 12 years of age and older caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum.

Source: US FDA prescribing information

Dosing overview

Apply ERTACZO cream, 2% twice daily for 4 weeks. Apply a sufficient amount of ERTACZO cream, 2% to cover both the affected areas between the toes and the immediately surrounding healthy skin. Use ERTACZO cream, 2% for the full treatment time recommended by the physician, even though symptoms may have improved. Dry the affected area(s) thoroughly before application, if using ERTACZO cream, 2% after bathing. Wash hands after use. Avoid the use of occlusive dressings or wrappings. For topical use. Not for ophthalmic, oral, or intravaginal use. Apply ERTACZO cream, 2% to the affected and immediate surrounding area(s) twice daily for 4 weeks.

Source: US FDA prescribing information

Warnings and precautions

Local Adverse Reactions If irritation develops, discontinue treatment and institute appropriate therapy. Physicians should exercise caution when prescribing ERTACZO cream, 2%, to patients known to be sensitive to azole antifungals since cross-reactivity may occur.

Source: US FDA prescribing information

Side effects

- Most common adverse reactions observed in clinical trials (incidence >2%) were contact dermatitis, dry skin, burning skin, application site skin tenderness.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

1 presentations of Sertaconazole, sorted by availability.

MedicineManufacturerRegisterAvailability
Ertaczo 2% creamTopicalLacer PharmaUS FDAAvailable on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 10 December 2003Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Sertaconazole available for export from India?

Yes, on request. MedsAcross lists 1 presentations of Sertaconazole and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Sertaconazole have?

The catalogue lists 1 brand names for Sertaconazole, including Ertaczo.

Is Sertaconazole approved by the US FDA?

Yes. The US FDA first approved Sertaconazole on 10 December 2003, according to Drugs@FDA.

Does Sertaconazole need cold chain shipping?

No listed presentation of Sertaconazole is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

References

  1. Ertaczo prescribing information (Coral Way Pharma). U.S. National Library of Medicine, DailyMed. Retrieved 7 April 2026

Request Sertaconazole for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.